Lanean...

A Two-step Binding Model of PCSK9 Interaction with the Low Density Lipoprotein Receptor

PCSK9 (proprotein convertase subtilisin-like/kexin type 9) is an emerging target for pharmaceutical intervention. This multidomain protein interacts with the LDL receptor (LDLR), promoting receptor degradation. Insofar as PCSK9 inhibition induces a decrease in plasma cholesterol levels, understandin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yamamoto, Taichi, Lu, Christine, Ryan, Robert O.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Biochemistry and Molecular Biology 2011
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3037659/
https://ncbi.nlm.nih.gov/pubmed/21149300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M110.199042
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!